IMMUNOSENS Co., Ltd. announced that it has raised a round of funding from a new investor, Shimadzu Future Innovation Fund L.P., a fund co managed by Global Brain Corporation and Shimadzu Corporation on November 14, 2025. The company issued convertible preferred shares in the transaction.
Shimadzu Corp is a Japan-based company mainly engaged in the research, development, manufacture, sale and maintenance of scientific and precision equipment. The Company has four segments. Testing and Measuring Instruments segment is engaged in the provision of chromatographic analysis systems, mass spectrometry systems, light analysis systems, thermal analysis systems, bio-related analysis systems, water quality measurement systems and others. Medical Equipment segment is engaged in the provision of X-ray television (TV) systems, angiography systems, X-ray imaging systems and others. Aircraft Equipment segment is engaged in the provision of flight control systems, air management systems, cockpit display systems and others. Industrial Equipment segment is engaged in the provision of turbomolecular pumps and others. The Company is also engaged in the leasing and management of real estate business.
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
